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Sciences  case  study.  The  DCC  SCARP  project,  funded  by  the  Joint  Information
Systems Committee (JISC), investigates disciplinary attitudes and approaches to data






The purpose of  this case study  is  to profile and scope  the work of  the Edinburgh
Mouse  Atlas  Project  in  relation  to  digital  curation  processes  and  activities
undertaken  by  the  researchers  working  on  the  project,  and  the  users  and
stakeholders for the services and products provided by the project. One aspect of
digital  curation  is  the  process  of  establishing  and  developing  infrastructure  to








disciplinary  setting;  life  sciences  and  specifically  model  organism  research,  the
production and use of curated databases, image based studies of development (wild‐


















As a  short  study,  the methods adopted aimed  for a broad profile of  the curation
practices employed  in support of  the research being undertaken.   Principally,  the






Atlas  Project  of  documentation  (primarily  EMAGE  documentation)  used  by  the
research group to describe their processes and product (e.g. Mouse Atlas) both for





to  provide  a  graphical  high‐level  overview  of  the  stages  required  for  successful
curation and preservation of data. “The model can be used to plan activities within
an organisation or consortium to ensure that all necessary stages are undertaken,
each  in  the  correct  sequence.  The  model  enables  granular  functionality  to  be







effectively  to  facilitate  further  research.   The  scope  for  the  development  of  the
EMAGE database has been well defined and there is evidence that the EMAGE team
is effectively meeting all set objectives.   Furthermore, market research has shown














which  limits  the  tracking and error  checking of data  into  the EMAGE database; a
quality  assurance process  in which  the high quality of data displayed appears  to
depend  upon  human  intervention,  where  curated  data  is  being  checked  and
corrected  by  the  senior  editor,  and  where  there  is  no  formal  process  for  the
correction of errors.
Nonetheless, with high data  throughput crucial to increasing the opportunities for
discovering  novel  genes,  the  team  has  recognised  that  greater  use  of  improved
curation  tools  and  methods  represents  a  means  of  potentially  increasing
effectiveness; and on an associated theme, developments in tools and methods are
accepted  as  essential  for  the  continued  maintenance  and  sustainability  of  the




rate  of  data  entry.   In  particular,  attention  to  a  revision  of  the  EMAGE  data
management  (administration)  tool  is expected to pay early dividends, particularly
through a consequent increase in the rate of curation, and automation of a number
of  steps  in  the  process  is  also  to  be  encouraged.   In  support  of  this  objective,
documenting  the  curation  policies  and  activities  applied  should  include  the
production of practical step‐by‐step guidelines for the practice of curation.   Given





Researchers  and  research‐based organisations  in  the  life  sciences  are not  simple
consumers  of  information  services  provided  by  publishers,  libraries  and  others



























investments  (Chu,  2005).  However,  despite  projects  of  strong  growth  there  are
challenges in the market which mainly focus on:











• The  perception  that  bioinformatics  tools  are  restricted  for  use  to  only
specialised end user groups
• The continual consolidation of bioinformatics and life sciences companies.
The  bioinformatics  market  is  being  driven  by  the  exponential  growth  of  novel
biological  discoveries  as  it  has  been  estimated  that  approximately  1  terabyte  of
biological information is generated per week. Thus, there is a need for information
technology to aid  in the development and maintenance of curated databases. For
biology,  the  use  and  effectiveness  of  text  data  mining  and  natural  language
techniques  is  challenging. This  is mainly due  to  the nomenclature and ontologies
used. However, the development and use of information extraction techniques for






genome  sequencing  data  leading  to  more  data  about  gene  expression,  gene
positioning  and  phenotypic  analysis  (genotype‐phenotype  associations)  being
generated.  One  of  the  main  objectives  in  bioinformatics  is  to  exploit  new
technologies  to construct databases  that are and easily available  for consultation
(Leonelli, 2008).
The  term  ‘curated database’ describes a database, or  repository, whose content,
often  about  a  specialised  subject,  has  been  obtained  by  extensive  human  effort
through  consultation,  verification,  aggregation  of  existing  sources  and  the
interpretation of new data  (often experimental). Thus, curated databases tend to
represent  the  efforts  of  a  dedicated  group  of  people  that  wish  to  produce  a
definitive  description  of  a  specific  subject  area.  As  scientific  research  data  has
become more available by being published electronically there has been a significant













• Evolution of  the database schema and structure;  to accommodate research
and  development  of  the  database,  new  scientific  discoveries  and  highlight
relations from the data collected
• Finding  a  vocabulary  and  format  that  allows  data  to  be  accessible  and
retrievable to all research groups

































• Molecular  databases  such  as;  Nucleotide  and  Protein  Sequences,
Protein Structures, Complete Genomes, Taxonomy, Expression and
Chemical databases





standard within  the  life sciences domain  is  ‘UniProt’  (Bairoch and Apweiler,










number  of  hierarchies  constructed  over  an  underlying  database  of  entries9. The
Open Biomedical Ontologies10 (OBO), sanctioned by a consortium of specialists,








provides  information  on many  of  the  other  reliable,  highly  standardised,  freely
available, well‐structured controlled vocabularies.
2.5 The Cost and Scalability of Curated Databases
The  economic  model  for  the  distribution  of  research  papers  has  shifted  from
academics  paying  to  get  their  research  into  print  and  disseminated,  to  papers
becoming accessible  through  the publishing of  articles electronically.  The  idea of
open access is that the initial costs should be paid for by the person (or institution or
grant)  responsible  for  a  publication  and  thereafter  the  research  article  should
become freely available. A key question is whether this economic model is suitable
for  curated  databases  which  are  open  access,  because  unlike  research  papers
curated databases are constantly updated and it is often difficult to obtain funding
for  future maintenance and sustainability  (Houghton  et  al,  2009). Whether users




working  full‐time  on  the  proteomic  database, UniProt  (Buneman  et al,  2008). A
breakdown of the Edinburgh Mouse Atlas Project costs is discussed in Section 12.1;
however,  determining  the  process  and  feasibility  of  scaling  up  the  project,
particularly the EMAGE team, would be interesting to review in more detail.
2.6 The Standards of Curated Databases
Standardising  and  structuring  forms  of  data,  such  as  life  sciences  activities  and
outputs, is becoming increasingly important in the progress and development of life
sciences  research.  Researchers’  involvement  in  developing  and  conforming  to
international standards is vital. However the challenges which lead to inefficiencies
and  lack  of  coordination  include  the  variation  in  publication  formats  of  existing
databases and accessibility to certain scientific information sources.




scientific  findings  and  due  to  the  data  publication  policy  of  journals,  or  strict
selection criteria, a large amount of data produced in the course of experiments is
discarded without being circulated to the wider community. These restrictions do
not  apply  to  curated  databases;  however  it  is  crucial  that  the  quality  of  data
collected by curated databases is high, and that the researchers’ results are reported







The  Microarray  Gene  Expression  Data  (MGED)  Society  is  an  international
organisation of biologists, computer scientists and data analysts that aim to facilitate
biological and biomedical discovery through data integration. In 2001, the European
Bioinformatics  Institute  (EBI) published a  standard  for presenting and exchanging
microarray data known as Minimum  Information About a Microarray Experiment
(MIAME)  (Brazma  et  al  ,  2001)  for MGED  and  recently,  the  society  has  set  up  a





data  integration,  exchange  and  comparison.  For  example,  in  2007  the  European










The  EMAP was  initially  a  collaborative  effort  between  the MRC Human Genetics
Unit,  Edinburgh and  the Section of Biomedical  Sciences, University of  Edinburgh.
Currently, EMAP is solely funded by the MRC.
Dr. Duncan Davidson and Prof. Richard Baldock received funding to commence the





the  success  of  the  project  is  the  knowledge  and  expertise  of  the  team  and  the




accompanying  databases  to  be  a  community  resource  for  spatially mapped  data
during mouse embryonic development. Ultimately, to allow users to view complex






hypothesised  structure.  The  atlas  also  includes  a  time‐dependent  anatomical
ontology  to enable mapping between  the ontology and  the spatial models  in  the






cross‐section  of  scientists  and  software  developers  (approximately  ratio  1:3)  is
impressive and vital for the success of their work. Time was spent with both Prof.
Richard Baldock  and Dr. Duncan Davidson,  and  the other members of  the EMAP
team and EMAGE editorial staff  listed below (Table 1). All were approachable and
took  time  to  address  questions  asked.  The  EMAGE  editors  and  database  service









they have  invaluable experience,  appear  to work  together well  and efficiently. A
number of internal meetings were also attended in which open issues and forward
planning was  addressed  in  an  informal,  interactive manor. No external meetings
were attended and unfortunately it was not possible to attend the Scientific Advisory
Board (SAB) meeting in December 2008.














































• Dr.  Alvis  Brazma: Head of ArrayExpress.  European BioInformatics  Institute,
European Molecular Biology Laboratory, Hinxton, UK.
• Prof. Steve Brown: Director, MRC Mammalian Genetics Unit, Harwell, UK.
• Dr.  Janan  Eppig:  Senior  Staff  Scientist,  Mouse  Genome  Informatics,  The
Jackson Laboratory, Bar Harbor, USA.
• Dr.  Graham  Kemp:  Associate  Professor,  Bioinformatics  Research  Group,
Chalmers University of Technology, Goteborg, Sweden.
• Dr.  Suzanna Lewis:  Informatics Group Leader, Berkeley Drosophila Genome
Project, Berkeley, USA.








Prof.  Richard  Baldock  believes  that  the  EMAP  provides  a  global  centre  for
mammalian  spatial mapping  and  text  annotation.  Currently,  there  are  no mouse
embryo databases that are  in direct competition with EMAGE, and few databases




the  1st  INCF Workshop  on Mouse  and  Rat  Brain  Digital  Atlasing  Systems15. The
workshop report gives an introduction to digital atlasing research and the need for
open standards and protocols.


















• BGED  (Brain  Gene  Expression  Database):  A  database  that  contains  gene








• GEISHA  (Gallus Expression  In Situ Hybridization Analysis): A centralized and
























the definitive  publications  of mouse  embryonic  development  by  Theiler  (Theiler,
1989) and Kaufman (Kaufman, 1992). From these studies a series of interactive three‐















• Offer  high‐quality  annotation  and  curation  of  gene  expression  data  in  the
spatio‐temporal and anatomical framework of the EMAP Digital Atlas
• Generate and offer methods for analysis of gene expression data
• Be  used  in  the  broader  context  with  other  bioinformatics  resources  to
generate a tool for understanding the genetic control of mouse development.
EMAGE data comprises the original raw data, processed data (mapping, image size
compression)  and  the website  interface of  descriptive  and  image  files with  their










objectives,  which  includes  increasing  collaborations  and  international  projects,










places  detailed  below.  Data  is  received  in  a  number  of  different  formats,  then
selected and transformed to a structured format. The data is then described, using
the MISFISHIE metadata standard, to enable the data to be discovered through their




From  the  literature,  published  data  from  journals  such  as;  Development,
Developmental Biology, Mechanisms of Development and Gene Expression Patterns.
• In  collaboration with  the Gene Expression Database  (GXD, Section 8.1);  the
Gene Expression Literature  Index (GELI)  is an  index complied by the GXD of




scientific  publications  from  over  150  journals  that  contain  mouse  in  situ
expression data. This includes information on the authors, gene/protein assay,
whether  the  samples  were whole‐mount  or  sectioned  and  the  age  of  the
specimens involved. To date, information for 3986 images for 1188 genes has
enabled at least one whole‐mount image per gene to be annotated.
• From  large‐scale  projects  and  screens,  such  as  EURExpress,  Mahoney




are actively encouraged to deposit  their in situ gene expression data  in  the
















each  journal  (e.g. whether  agreements  have been  reached between  EMAGE and
each  journal  publisher  or  if  a  journal  publishes  under  a  Creative  Commons
Attribution License).
4.3.2 User Submission Options for Data
The  EMAGE  data  model  (Figure  2)  enables  users  to  search  the  central  EMAGE
database, make  their  own private  local  database  for  in‐lab data management or
submit  gene  expression  data  for  curation  and  inclusion  in  the  publicly  available
EMAGE  database.  The  data  submission  options,  that  the  EMAGE  team  actively
encourage, are to22:
• Primarily, follow the EMAGE electronic data submission instructions to make





public  EMAGE database.  Information  can be  sent by post  (e.g.  on  compact














approximately  2,400  (Figure  4).  Initially,  there was  a  steady  increase  in  EMAGE
database growth, however after May 2006 to November 2007 the number of data












and  the  current  target  is  1,500 data  entries per  annum  (Figure 3).  Thus,  there  is
greater value in entering data for more genes at fewer stages than for fewer genes
at more stages. Data has been obtained primarily  from the  literature,  large‐scale
projects and screens (Section 8). A recent publication on EMAGE stated that 8% of


















into  the  public  EMAGE  database.  The  number  of  individual  entries  and  genes
represented  in the public EMAGE database over time; one entry = one annotated
representation of  the sites of expression  for one gene  from one or more original
assay  images  from one specimen. SAB  is  the  times of previous Scientific Advisory
Board Meetings.
4.3.5 Metadata  for Discovery and Administration
When  compiling  the  information,  the  EMAGE  editorial  team  strongly  encourage
those entering data  to  follow the proposed MISFISHIE guidelines24, to ensure the













































assurance  checks.  Reappraisal  of  data  that  fails  integrity  and  quality  checks  is





reagent  information  and  experimental  conditions.  The  quality  assurance  process
steps are to:
















A  potential  limiting  step  is  that  the  senior  editor  then writes  down  the  EMAGE






the  training  and development  of  the  curators  it may be  best  for  feedback  to  be




using  the  EMAGE database have highlighted  few errors, which  suggests  that  the
quality of curated data within the EMAGE database is of a high standard.













• The  degree  of morphological  similarity  between  the  data  embryo  and  the
EMAP embryo template that the data is spatially mapped onto.
The scores can be used to gauge the potential quality of each spatial annotation and
for  filtering  data  sets  for  spatial  analyses  (such  that  only  the  highest  quality
annotations are used, for example).
This simple approach of using a confidence score rather than percentages has been










by  ensuring  they  are:  in  an  acceptable  file  format  for  inclusion  in  the  dataset;






following  methods;  in  situ  hybridisation  (directed  against  RNA),




embryo and  the  raw data  images  (saved as  jpeg).  These are  shown  in EMAGE as




Unique  identifiers  are  assigned  to  the  data.  This  helps  maintain  provenance
information and ensures that the data can be cited.   Previously versioned curated






both  themselves  and  users  of  the  EMAGE  database,  although  there  are  some
copyright  issues. This “Access, Use and Reuse” step of  the DCC Curation Lifecycle











two  sets  of  EMAGE  entries  (gene,  stage  of  development,  expression  pattern,
anatomical structure) using the three most basic Boolean logic operators ‘and’, ‘or’

















database and  continue  to promote EMAGE  to  the  community  and educate users
(termed the ‘outreach programme’) by attending and presenting at conferences and




how  to  use  the  EMAGE  database  for  their  research  but  also  enables  users  to
understand what information is of key importance to ensure that their data can be
displayed in an accurate and informative manner in the database.






Head of GXD Database) enabled  the  reproduction of original data  images on  the
EMAGE website from 4 journals (Development, Developmental Biology, Mechanisms
of Development and Gene Expression Patterns).
To  date,  the  EMAGE  team  have  arranged  individual  legal  agreements  with  the
publishers of 24 journals (that collectively house over 80% of published in situ gene















The  EMAP  database  is  not  currently  commercialised  and  there  are  no  plans  to
commercialise the database in the future. Thus:
• The  annotation  and  curation of  all  gene  expression  data  is  freely  available
through EMAGE.




















The  standardisation  of  EMAGE  data  is  of  key  importance  to  the  success  of  the
EMAGE database  (Figure  5).  The use of metadata  standards  enables  current  and
future  interoperability  with  other  relevant  projects,  and  ensures  that  the  data
created can be accessed and administered over  the  long‐term. The DCC Curation
Lifecycle Model recommends that standards are used for description throughout the
curation  lifecycle,  and  that  the  representation  information  required  to  both
understand and render digital materials, and their metadata, are collected.
The  EMAGE  Team  are  actively  participating  in  the  development  of  appropriate



















The  EMAGE  team  actively  promote  standardisation  within  the  life  sciences
community by:
• Being  part  of  an  international  consortium  that  is  developing  a  minimum
specification for in situ hybridisation and immunohistochemistry experiments
(known as  ‘MISFISHIE’29), and has developed a schema that can be used to
record  all  aspects  of  an  in  situ  experiment.  In  addition,  a  separate  in  situ
detection reagent database of all probes and antisera used in EMAGE will be
developed.
• Promoting  database  interoperability  and  integration  by  sharing  EMAGE
information on the Mouse Resource Browser  (MRB) developed by the BioIT
Unit  at  Alexander  Fleming  Biomedical  Sciences  Research  Center  as  an
electronic aid  for  searching and  retrieving  information about online mouse
resources30.







project  at  the  Jackson  laboratory  (Dr. Martin  Ringwald),  USA.  GXD  collects  and
integrates  the  gene  expression  information  in  the Mouse  Genome  Informatics32
(MGI)  databases  to  enable  the  scientific  community  to  view  gene  expression
information about  the mouse  in  the context of genetic,  sequence,  functional and


















• GXD  and  EMAGE  follow  common  guidelines  that  result  in  consistent
descriptions that can be shared between the two databases
• The EMAP mouse nomenclature database has been incorporated in the GXD













the  information  already  compiled  by  the  EURExpress  consortium,  EMAGE  has




for  renal  development  and  disease  to  enable  their  proteins  and  actions  to  be
researched further. This is achieved by a consortium of leading scientists, clinicians
and  industry  partners  (particularly  small  and medium‐sized  enterprises) working
together to develop novel technologies and discovery tools that could be applied to
kidney  research34. In March 2008, the  EuReGene Kidney Atlas and Expression
databases  with  movies  of  kidney  development,  the  ontology  database  and
EuReGene’s mutant phenotype data were made publically available.35















the  GUDMAP  in  situ  and  micro‐array  gene  expression  database  to  facilitate
genitourinary  development  and  disease  research.  The  linking  of  GUDMAP  gene








based  informatics  technologies,  ethical  framework  study  and  feasibility  study  to







Human  Genetics  Unit,  Edinburgh)  and  Dr.  Mike  Dixon  (School  of  Dentistry,
Manchester University) and is funded as part of the National Institute of Dental and
Craniofacial Research (NIDCR) Center38.










Roslin  Institute  (University  of  Edinburgh),  the  MRC  Human  Genetics  Unit
(Edinburgh), University College London and Trinity College Dublin)  funded by  the
BBSRC  is  to develop a  three‐dimensional  atlas  and gene expression database  for
chick development with cross comparisons to the mouse via the EMAGE database39.
Expression  data  will  focus  on  approximately  1,000  genes  (identified  as  having
expression in several organiser regions) at two stages of development.
4.9 Planning Curation and Preservation
The  EMAGE  Team  have  a  number  of  processes,  tools  and  resources  which  are




EMAGE will  continue  to  source  and  develop  processes  to  “Curate  and  Preserve”
spatial data  in  the developing mouse embryo.  It  is of  key  importance  to develop




continuation  of  funding  to  ensure  that  curation  can  continue.  Planning  future





specific,  for example  there are  specific  SOPs  for  the EURExpress project,  and  the















bug  fixing and  release of  the  tool.  Tools  that  are only used  internally  tend  to be
tested  as  the  scientists  use  the  tool whereas  those  tools  that  are made publicly































data  curation  include  the  mouse  development  atlas  information  that  provides
definitions for all stages and individual Theiler Stages and several external sources
(information  on  gene/protein  symbol  and  name,  mouse  strains,  mouse  alleles,
nucleic  acid  sequences,  amino  acid  sequences,  probes  and  antisera  and mouse
embryo anatomy descriptions)40.







for  signal  extraction  and  tissue  section  registration  to  allow  a  partial
automated approach to spatial annotation
• Complete redesign of  the EMAGE website  (incorporated drop‐down menus,
quick  search  functions  and  more  extensive  user  help  information)  and
associated  User  Query  Interfaces  (search  by  gene/protein  name  symbol,
anatomical structure name, spatial region)
• Continual  database  development  from  an  object‐oriented  to  relational
database  structure, which  includes new SQL access  for  text data  in EMAGE


























































• The  Coordination  and  Sustainability  of  International  Mouse  Informatics
Resources  (CASIMIR) which  focuses on  the co‐ordination and  integration of
databases that contain experimental data relevant to the use of the mouse as
a  model  organism  for  human  disease.  The  aim  is  to  set  standards  and





consortium  (32  research organisations,  universities  and  companies  from  13
countries), led by European Bioinformatics Institute (EBI) Director Prof. Janet
Thornton41, is working together to determine how to transform European




users and potential users of e‐Science tools and techniques  to  further  their
research.
















No  business  model  documentation  was  reviewed  for  either  EMAP  or  EMAGE




project  collaborators  although  the  EMAGE  team  may  benefit  from  obtaining  a
clearer  understanding  of  the  future  plans  for  EMAP  and  how  this  will  direct





mapping  of  data  (for  example,  gene  expression)  to  a  structured  framework  (for






stakeholders)  of  EMAP  (Appendix  7)  prior  to  mapping  of  the  EMAGE  curation
processes against the DCC Curation Lifecycle Model (Appendix 8). This ensured that
the  case  study  summary  report  covered many  aspects  of  the  curation  practices
without exploring any  in specific detail. A key  finding of  the case study  is  that,  to
optimise  data  curation  a  number  of  lifecycle  management  issues  need  to  be
continually assessed and further steps taken.












Data,  any  information  in  binary  digital  form,  is  at  the  centre  of  the  Curation
Lifecycle. This includes:
Digital  Objects:  simple  digital  objects  (discrete  digital  items  such  as  text  files,








Assign  administrative,  descriptive,  technical,  structural  and  preservation
metadata,  using  appropriate  standards,  to  ensure  adequate  description  and








possible  for  the  team  to work with  researchers  individually however  the  team
realise  the  importance  of  standardisation  and  actively  address  and  promote
standardisation methods within the life sciences community.
NEXT STEPS
As  the  number  of  collaborations  and  externally  funded  projects  increase  the
standardisation of curated data and the transfer of  the mouse atlas knowledge
will  continue  to  be  of  key  importance.  It  is  important  that  the  EMAGE  team
continue  to  drive  forward  the  use  of  standardisation  and  transfer  their
experiences,  lessons  learnt  to  others  that  are working  on  similar  projects.  For






















Development of  tools  and methods:  There are various developments ongoing in
tools and methods and the  team recognise  that  for  the continual maintenance
and  sustainability  of  EMAGE  there  is  a  requirement  to  support  the  database
infrastructure as well as the interface.
Teamwork:  It was found that the EMAGE editorial  team were strong  in sharing
their expertise internally and externally. The fact that the team is small and work
















Create  data  including  administrative,  descriptive,  structural  and  technical
metadata.  Preservation metadata may  also  be  added  at  the  time  of  creation.
Receive  data,  in  accordance  with  documented  collecting  policies,  from  data
creators,  other  archives,  repositories  or  data  centres,  and  if  required  assign
appropriate metadata.
LIFECYCLE MANAGEMENT  ISSUES
Data  entry:  All  data  received  is  entered  into  the  EMAGE  database  using  the




Data  throughput:  High  throughput  is of key  importance  for  the success of  the
EMAGE database. It  is hoped that the focus on entering data for more genes at
fewer  stages  will  increase  the  likelihood  of  discovering  novel  genes  that
potentially overlap functionally and regulatory with known genes.  The continual
advance  to  increase  curation  efficiency  through  the  use  and  development  of
curation  tools  and  methods  was  evident  and  is  an  area  of  value  that  could
potentially be investigated in more detail.
Data  integration:  The  EMAGE  team  continues  to  research  and  develop  data




Optimise  data  management  and  entry  rate  by  rewriting  the  EMAGE  data












Evaluate  data  and  select  for  long‐term  curation  and  preservation.  Adhere  to
documented guidance, policies or legal requirements.
LIFECYCLE MANAGEMENT  ISSUES
Data  quality:  The  quality  of  data  that  is  saved  in  the  EMAGE  database  is















EMAGE  database.  Potentially,  the  Mantis  Bug  Tracker  system  could  be  used
initially  to  log  curation  errors  that  require  to  be  corrected  by  the  curators.
Efficiency could also be improved by the use of quality assurance reports so that










Undertake  actions  to  ensure  long‐term  preservation  and  retention  of  the
authoritative nature of data. Preservation actions should ensure that data remains
authentic, reliable and usable while maintaining its integrity. Actions include data

























EMAGE’s  activities  are  covered  by  copyright  agreements  with  the  relevant
publishers, there is a small portion of their work where the status remains unclear.
It  has  been  determined  that  ‘fair  dealing’  (or  ‘fair  use’  in  the USA) may  have
limited applicability for these activities.   Discussions are ongoing as to the most
appropriate way forward and include further investigation of copyright case law,
as well  as  the  possibility  of  joining with  other  bio‐curators  to make  collective
approaches to journals for permissions.
Data  analysis:  It was  found  that  no  structured  documentation  of  queries was




presents  a number of  new  challenges  for  the EMAGE  team.  The data  file  size,
whether  to show  images statically or  in  rotation and how users will be able  to




could  be  reduced  by  decreasing  the  number  of  duplicated  experiments  if
researchers  used  the  EMAGE  database  to  review  experiments  that  had  been
previously performed.
NEXT STEPS





















Obtaining  feedback  from  users  on  database  requirements,  improvement
suggestions, data errors and demand for additional links to external data sources.















Dispose  of  data,  which  has  not  been  selected  for  long‐term  curation  and





































of  information  on  how  the  project  has  been  scoped  and  driven,  who  the
stakeholders  are,  and  the  numerous  collaborations  and  international  projects
enabled the case study to be analysed and key findings reported. An initial mapping
of  the  EMAGE  curation  processes  against  the  DCC  Curation  Lifecycle  Model  is
provided however a more detailed review of this case study will result in a clearer
understanding  of  the  project’s  risks  which  will  enable  more  definitive
recommendations to be made. Thus, a more in depth review of the EMAP would be
beneficial.
The  DCC  and  appropriate  funders,  including  JISC,  should  support  further
investigation with the following recommended scope:
• Detailed discussions of  the key areas of EMAGE,  such as data  curation and






















• To map  the  relationships between data quality,  scalability and users of  the
EMAGE database.
• Explore current and future opportunities of sharing EMAGE data.
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Name Position  (funding  source)
Dr. Malcolm
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Development (a) 521 Nat Neurosci 5
Dev Biol (a) 435 Stem Cells 5
Nature 330 Cytogenet Genome Res 4
Mech Dev  (a) 309 EMBO Rep 4
Dev Dyn  (b) 220 Exp Mol Med 4
Genes Dev (x) 176 J Cardiovasc Electrophysiol 4
Mol Cell Biol  (b) 138 J Immunol 4





(b) 87 Neurosci Lett 4
J Biol Chem (b) 73 Biofactors 3
Cell (b) 72 Br J Haematol 3
Nat Genet 70 Cells Tissues Organs 3
Dev Cell (b) 65 Endocrinology 3
Neuron (b) 60 J Histochem Cytochem 3
Nat Methods 49 J Med Genet 3
Genesis (b) 48 Mol Reprod Dev 3
J Neurosci (b) 46 Mol Vis 3
Science 45 Nat Med 3
Hum Mol Genet 41 Transgenic Res 3
EMBO J 40 Am J Physiol Cell Physiol 2
Gene 40 Am J Physiol Heart Circ Physiol 2
Genomics 32 Angiogenesis 2
Blood 31 Biomarkers 2
Genome Res 31 Brain Res Gene Expr Patterns 2
BMC Dev Biol  (c) 30 Cancer Res 2




Oncogene 21 Diabetes 2
Differentiation 20 Eur J Hum Genet 2
FEBS Lett 20 Evol Dev 2
Mamm Genome 20 Int Immunol 2
Mol Cell Endocrinol 20 J Anat 2
Dev Genet 18 J Bioenerg Biomembr 2
Mol Cell Neurosci 17 J Cell Biochem 2
Biochim Biophys Acta 16 J Neurosci Res 2
Brain Res Dev Brain Res 16 Nat Biotechnol 2
J Am Soc Nephrol 16 Nat Cell Biol 2
Anat Embryol (Berl) 15 Nat Immunol 2







J Clin Invest 15 Pharmacogenomics J 2
Curr Biol 14 Reproduction 2
J Cell Biol 13 Toxicol Pathol 2
Mol Genet Metab 13 Traffic 2
Mol Hum Reprod 13 J Neurobiol 1




Cell Tissue Res 11 Am J Physiol Renal Physiol 1
Exp Cell Res 11 Anat Rec 1




Brain Res Mol Brain Res 10 BMC Cell Biol (c) 1
Gastroenterology 10 BMC Genomics (c) 1
J Bone Miner Res 10 Br J Dermatol 1
J Comp Neurol 10 Congenit Anom Kyoto 1
Mol Pharmacol 10 Connect Tissue Res 1
Nucleic Acids Res (c) 10 Cytogenet Cell Genet 1
Circ Res 9 Eur J Biochem 1
Genes Cells 9 Exp Eye Res 1
PLoS ONE (c) 9 FASEB J 1
Anat Rec A Discov Mol Cell Evol
Biol 8 Gut 1
Invest Ophthalmol Vis Sci 8 J Dermatol Sci 1
J Mol Biol 8 J Exp Zoolog B Mol Dev Evol 1
J Mol Cell Cardiol 8 J Leukoc Biol 1
Lab Invest 8 J Lipid Res 1
Mol Endocrinol 8 J Med Sci 1
PLoS Biol 8 J Mol Neurosci 1
Am J Pathol 7 J Neuropathol Exp Neurol 1
Dev Growth Differ 7 J Toxicol Environ Health A 1
DNA Cell Biol 7 Kidney Int 1
Neuroreport 7 Life Sci 1
PLoS Genet (c) 7 Mol Carcinog 1
Biochem J 6 Mol Cell 1
Biol Reprod 6 Mol Cells 1




J Invest Dermatol 6 Reprod Toxicol 1
J Reprod Dev 6 Teratology 1
Matrix Biol 6 Toxicol Lett 1






























Data  (output) Stakeholders  (output)
• Sharing of data
• User interface
• Documentation (internal and external) –
manual, partial automation, automation
guidelines for digital curation, promotional
materials
• Normalisation of imaging
• Who’s viewing the data globally
• Who’s downloading the data
• What are people doing with the data
• External reports
• Expert advice and guidance
• Collaborative networks – relationships with
key players, gain recognition, greater
exposure in the broader community, links to
other sciences, non‐science projects
• Support services
• Audit and certification – standards and
practice
• Who
• Where
• Global collaborations
• Cost
• Quality – accountability and efficiency
• Analysis, assessment of data
• Preservation – maintaining value, research
lifecycle
• Value of resources – expertise, process
development
• Testing of techniques/tools developed
• Raise awareness of curation issues
• Review other e‐sciences strategies that will
impact the digital curation process
